Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
Crossref DOI link: https://doi.org/10.1186/s12885-016-2994-6
Published Online: 2017-01-09
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakayama, Izuma
Shinozaki, Eiji
Matsushima, Tomohiro
Wakatsuki, Takeru
Ogura, Mariko
Ichimura, Takashi
Ozaka, Masato
Takahari, Daisuke
Suenaga, Mitsukuni
Chin, Keisho
Mizunuma, Nobuyuki
Yamaguchi, Kensei